DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
US Food and Drug Administration.
Dalteparin sodium approval for pediatric patients.
2019 . Accessed October 2021 at:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020287s072lbl.pdf
We do not assume any responsibility for the contents of the web pages of other providers.